Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab

被引：1

作者：

Bagnasco, Diego ^{[1
]}

Riccio, Anna Maria ^{[1
]}

De Ferrari, Laura ^{[1
]}

Caminati, Marco ^{[2
,3
,4
]}

Massolo, Alessandro ^{[5
]}

Senna, Gianenrico ^{[2
,3
,4
]}

Passalacqua, Giovanni ^{[1
]}

机构：

[1] Univ Genoa, IRCCS Policlin San Martino, Allergy & Resp Dis, Genoa, GE, Italy

[2] Verona Univ, Asthma Ctr, Verona, Italy

[3] Verona Univ, Allergy Unit, Verona, Italy

[4] Univ Verona, Gen Hosp, Dept Med, Verona, Italy

[5] Univ Pisa, Dept Biol, Ethol Unit, Pisa, Italy

来源：

EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷

关键词：

Biomarkers; Asthma; -; mechanism;

D O I：

10.1183/13993003.congress-2020.2230

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2230

引用

页数：2

共 50 条

[41] Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab [J].

Yang, Jieqiong ;

Busby, John ;

Heaney, Liam G. ;

Brightling, Chris E. ;

Pavord, Ian D. ;

Borg, Katie ;

Mcdowell, Pamela Jane ;

Diver, Sarah ;

Shrimanker, Rahul ;

Smith, Steven ;

Shepherd, Malcolm ;

Lee, Waiting Nicola ;

Chaudhuri, Rekha .

EUROPEAN RESPIRATORY JOURNAL, 2020, 56

[42] YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment [J].

Lai, Tianwen ;

Chen, Min ;

Deng, Zaichun ;

Lu, Yingying ;

Wu, Dong ;

Li, Dongming ;

Wu, Bin .

BMC PULMONARY MEDICINE, 2015, 15

[43] Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma [J].

Yildiz, Hanifi ;

Alp, Hamit Hakan ;

Sunnetcioglu, Aysel ;

Ekin, Selami ;

Cilingir, Buket Mermit .

HEART & LUNG, 2021, 50 (01) :177-183

[44] YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment [J].

Tianwen Lai ;

Min Chen ;

Zaichun Deng ;

Yingying Lǚ ;

Dong Wu ;

Dongming Li ;

Bin Wu .

BMC Pulmonary Medicine, 15

[45] Role of breast regression protein-39/YKL-40 in asthma and allergic responses [J].

Lee, Chun Geun ;

Elias, Jack A. .

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2010, 2 (01) :20-27

[46] Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy [J].

Bagnasco, Diego ;

Riccio, Anna Maria ;

De Ferrari, Laura ;

Massolo, Alessandro ;

Caminati, Marco ;

Manfredi, Andrea ;

Senna, Gianenrico ;

Passalacqua, Giovanni .

EUROPEAN RESPIRATORY JOURNAL, 2020, 56

[47] YKL-40 tissue expression and plasma levels in patients with ovarian cancer [J].

Hogdall, Estrid V. S. ;

Ringsholt, Merete ;

Hogdall, Claus K. ;

Christensen, Ib Jarle ;

Johansen, Julia S. ;

Kjaer, Susanne K. ;

Blaakaer, Jan ;

Ostenfeld-Moller, Lene ;

Price, Paul A. ;

Christensen, Lise H. .

BMC CANCER, 2009, 9

[48] Serum YKL-40 (chitinase 3-like protein 1) levels in migraine patients during an attack [J].

Horasanli, Bahriye ;

Caliskan Sak, Zeynep ;

Ozsahin, Aysun ;

Ucar Karabulut, Keziban .

NEUROLOGY ASIA, 2023, 28 (04) :985-989

[49] Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis [J].

Crimi, Claudia ;

Campisi, Raffaele ;

Cacopardo, Giulia ;

Doria, Giacomo ;

Intravaia, Rossella ;

Morena, Porto ;

Sabrina, Genco ;

Sorrentino, Ramona ;

Crimi, Nunzio .

EUROPEAN RESPIRATORY JOURNAL, 2019, 54

[50] Severe asthma in obese patients: what to expect with Mepolizumab? [J].

Da Cunha Fonseca, A. ;

Machado, D. ;

Pascoal, I. ;

Franco, I. ;

Lima, R. .

EUROPEAN RESPIRATORY JOURNAL, 2022, 60

← 1 2 3 4 5 →